Clinical Trials Browser

Phase 1/2 × Vaccines × 1 year × Clear all

NCT01720836 2025-10-21

Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Phase 1/2 Recruiting

Carcinoma, Non-Small-Cell Lung